12:00 AM
Mar 23, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Takeda, Teijin sales and marketing update

Takeda's Takeda Pharmaceuticals North America Inc. unit launched Uloric febuxostat in the U.S. for chronic management...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >